107 related articles for article (PubMed ID: 20523070)
1. The pathophysiological roles of PI3Ks and therapeutic potential of selective inhibitors in allergic inflammation.
Takeda M; Ito W; Tanabe M; Ueki S; Kihara J; Kato H; Tanigai T; Kayaba H; Sasaki T; Chihara J
Int Arch Allergy Immunol; 2010; 152 Suppl 1():90-5. PubMed ID: 20523070
[TBL] [Abstract][Full Text] [Related]
2. Allergic airway hyperresponsiveness, inflammation, and remodeling do not develop in phosphoinositide 3-kinase gamma-deficient mice.
Takeda M; Ito W; Tanabe M; Ueki S; Kato H; Kihara J; Tanigai T; Chiba T; Yamaguchi K; Kayaba H; Imai Y; Okuyama K; Ohno I; Sasaki T; Chihara J
J Allergy Clin Immunol; 2009 Apr; 123(4):805-12. PubMed ID: 19232703
[TBL] [Abstract][Full Text] [Related]
3. Phosphoinositide 3-kinase-delta inhibitor reduces vascular permeability in a murine model of asthma.
Lee KS; Park SJ; Kim SR; Min KH; Jin SM; Puri KD; Lee YC
J Allergy Clin Immunol; 2006 Aug; 118(2):403-9. PubMed ID: 16890765
[TBL] [Abstract][Full Text] [Related]
4. Phosphoinositide 3-kinase delta inhibitor as a novel therapeutic agent in asthma.
Park SJ; Min KH; Lee YC
Respirology; 2008 Nov; 13(6):764-71. PubMed ID: 18811876
[TBL] [Abstract][Full Text] [Related]
5. Role of the phosphoinositide 3-kinase p110delta in generation of type 2 cytokine responses and allergic airway inflammation.
Nashed BF; Zhang T; Al-Alwan M; Srinivasan G; Halayko AJ; Okkenhaug K; Vanhaesebroeck B; Hayglass KT; Marshall AJ
Eur J Immunol; 2007 Feb; 37(2):416-24. PubMed ID: 17236236
[TBL] [Abstract][Full Text] [Related]
6. Aerosolized phosphoinositide 3-kinase gamma/delta inhibitor TG100-115 [3-[2,4-diamino-6-(3-hydroxyphenyl)pteridin-7-yl]phenol] as a therapeutic candidate for asthma and chronic obstructive pulmonary disease.
Doukas J; Eide L; Stebbins K; Racanelli-Layton A; Dellamary L; Martin M; Dneprovskaia E; Noronha G; Soll R; Wrasidlo W; Acevedo LM; Cheresh DA
J Pharmacol Exp Ther; 2009 Mar; 328(3):758-65. PubMed ID: 19056934
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic potential of phosphatidylinositol 3-kinase inhibitors in inflammatory respiratory disease.
Ito K; Caramori G; Adcock IM
J Pharmacol Exp Ther; 2007 Apr; 321(1):1-8. PubMed ID: 17021257
[TBL] [Abstract][Full Text] [Related]
8. L-Selectin is required for the development of airway hyperresponsiveness but not airway inflammation in a murine model of asthma.
Fiscus LC; Van Herpen J; Steeber DA; Tedder TF; Tang ML
J Allergy Clin Immunol; 2001 Jun; 107(6):1019-24. PubMed ID: 11398079
[TBL] [Abstract][Full Text] [Related]
9. Targeting phosphoinositide 3-kinase δ for allergic asthma.
Rowan WC; Smith JL; Affleck K; Amour A
Biochem Soc Trans; 2012 Feb; 40(1):240-5. PubMed ID: 22260698
[TBL] [Abstract][Full Text] [Related]
10. Doxycycline reduces airway inflammation and hyperresponsiveness in a murine model of toluene diisocyanate-induced asthma.
Lee KS; Jin SM; Kim SS; Lee YC
J Allergy Clin Immunol; 2004 May; 113(5):902-9. PubMed ID: 15131573
[TBL] [Abstract][Full Text] [Related]
11. Repressor of GATA regulates TH2-driven allergic airway inflammation and airway hyperresponsiveness.
Hirahara K; Yamashita M; Iwamura C; Shinoda K; Hasegawa A; Yoshizawa H; Koseki H; Gejyo F; Nakayama T
J Allergy Clin Immunol; 2008 Sep; 122(3):512-20.e11. PubMed ID: 18620745
[TBL] [Abstract][Full Text] [Related]
12. PI3K delta and PI3K gamma: partners in crime in inflammation in rheumatoid arthritis and beyond?
Rommel C; Camps M; Ji H
Nat Rev Immunol; 2007 Mar; 7(3):191-201. PubMed ID: 17290298
[TBL] [Abstract][Full Text] [Related]
13. Role of phosphoinositide 3-kinase p110 delta in TLR4- and TLR9-mediated B cell cytokine production and differentiation.
Dil N; Marshall AJ
Mol Immunol; 2009 Jun; 46(10):1970-8. PubMed ID: 19362372
[TBL] [Abstract][Full Text] [Related]
14. The role of PI3K in immune cells.
Koyasu S
Nat Immunol; 2003 Apr; 4(4):313-9. PubMed ID: 12660731
[TBL] [Abstract][Full Text] [Related]
15. Novel immunomodulatory oligonucleotides prevent development of allergic airway inflammation and airway hyperresponsiveness in asthma.
Agrawal DK; Edwan J; Kandimalla ER; Yu D; Bhagat L; Wang D; Agrawal S
Int Immunopharmacol; 2004 Jan; 4(1):127-38. PubMed ID: 14975367
[TBL] [Abstract][Full Text] [Related]
16. Targeting phosphoinositide 3-kinase gamma to fight inflammation and more.
Barberis L; Hirsch E
Thromb Haemost; 2008 Feb; 99(2):279-85. PubMed ID: 18278175
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of class II phosphoinositide 3-kinase alpha expression below a critical threshold induces apoptotic cell death.
Elis W; Triantafellow E; Wolters NM; Sian KR; Caponigro G; Borawski J; Gaither LA; Murphy LO; Finan PM; Mackeigan JP
Mol Cancer Res; 2008 Apr; 6(4):614-23. PubMed ID: 18403640
[TBL] [Abstract][Full Text] [Related]
18. Cloning and characterization of a novel class II phosphoinositide 3-kinase containing C2 domain.
Misawa H; Ohtsubo M; Copeland NG; Gilbert DJ; Jenkins NA; Yoshimura A
Biochem Biophys Res Commun; 1998 Mar; 244(2):531-9. PubMed ID: 9514948
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptor gamma agonist down-regulates IL-17 expression in a murine model of allergic airway inflammation.
Park SJ; Lee KS; Kim SR; Min KH; Choe YH; Moon H; Chae HJ; Yoo WH; Lee YC
J Immunol; 2009 Sep; 183(5):3259-67. PubMed ID: 19641141
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of matrix metalloproteinases prevents allergen-induced airway inflammation in a murine model of asthma.
Kumagai K; Ohno I; Okada S; Ohkawara Y; Suzuki K; Shinya T; Nagase H; Iwata K; Shirato K
J Immunol; 1999 Apr; 162(7):4212-9. PubMed ID: 10201949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
